title: Heart disease: recruitment of MEF2 activity by β-blockers wards off cardiomyocyte death.
authors.affiliation: Department of Biology, York University, Toronto, Canada.|Muscle Health Research Centre (MHRC), York University, Toronto, Canada.|Centre for Research in Biomolecular Interactions (CRBI), York University, Toronto, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Hashemi
authors.affiliation: Department of Biology, York University, Toronto, Canada.|Muscle Health Research Centre (MHRC), York University, Toronto, Canada.|Centre for Research in Biomolecular Interactions (CRBI), York University, Toronto, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Wales
authors.affiliation: Department of Biology, York University, Toronto, Canada.|Muscle Health Research Centre (MHRC), York University, Toronto, Canada.|Centre for Research in Biomolecular Interactions (CRBI), York University, Toronto, Canada.
authors.forename: T
authors.initials: T
authors.lastname: Miyake
authors.affiliation: Department of Biology, York University, Toronto, Canada.|Muscle Health Research Centre (MHRC), York University, Toronto, Canada.|Centre for Research in Biomolecular Interactions (CRBI), York University, Toronto, Canada.|Centre for Research in Mass Spectrometry (CRMS), York University, Toronto, Canada.
authors.forename: J C
authors.initials: JC
authors.lastname: McDermott
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis; D002316:Cardiotonic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002470:Cell Survival; D006331:Heart Diseases / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D064326:MEF2 Transcription Factors / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000502:physiology*
chemical_list: D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D064326:MEF2 Transcription Factors